MSGP — Medsmart Income Statement
0.000.00%
FinancialsHighly SpeculativeMicro Cap
- $0.00m
- $1.19m
- $0.54m
Annual income statement for Medsmart, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
| 2009 December 31st | 2010 December 31st | R2011 December 31st | 2012 December 31st | 2013 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M | 
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K | 
| Standards: | — | USG | — | — | — | 
| Status: | Final | Final | Final | Final | Final | 
| Revenue | |||||
| Total Revenue | 0.02 | 0.001 | 0.027 | 0.048 | 0.542 | 
| Cost of Revenue | |||||
| Gross Profit | 0.016 | 0.001 | 0.012 | 0.021 | 0.268 | 
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Total Operating Expenses | 0.106 | 0.291 | 0.418 | 0.669 | 0.814 | 
| Operating Profit | -0.086 | -0.29 | -0.391 | -0.621 | -0.273 | 
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.005 | -4.37 | -0.917 | -9.95 | 2.67 | 
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.005 | -4.37 | -0.917 | -9.95 | 2.67 | 
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.005 | -4.37 | -0.917 | -9.95 | 2.67 | 
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -0.005 | -4.37 | -0.917 | -9.95 | 2.67 | 
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -14.3 | -3,178 | -369 | -197 | 8.53 | 
| Dividends per Share |